Azeem Latib
Azeem Latib is an expert in Cardiology at Montefiore Medical Center (United States). As of October 2026, ScienceLeadR ranks Azeem Latib in the top 1% of experts worldwide for Tricuspid Valve Insufficiency, Mitral Valve Insufficiency and Ventricular Outflow Obstruction. Azeem Latib has authored 1,348 publications, the most recent in 2026, and is an investigator in 49 clinical trials, 19 of them ongoing. SLR score: 5,215 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Surgery - Thoracic And Cardiovascular Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 1348
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Timing of revascularisation in patients undergoing high-risk percutaneous coronary intervention and Transcatheter aortic valve implantation: insights from the ASCoP registry. PMID 42838145 — registries, incidence, percutaneous coronary intervention, aortic valve, transcatheter aortic valve replacement, therapeutics | Int J Cardiol | 2026 | 0 |
| Safety and Effectiveness of a Novel Laser-Based Intravascular Lithotripsy System for Coronary Calcium: FRACTURE Study. PMID 42933913 — stents, safety, coronary artery disease, percutaneous coronary intervention, lasers, calcium, tomography, optical coherence, wounds and injuries, lithotripsy | JACC Cardiovasc Interv | 2026 | 1 |
| PASCAL Precision System Outcomes by Implant Location and Lesion Location in Degenerative Mitral Regurgitation Patients From the STS/ACC TVT Registry. PMID 42924766 — registries, mortality, heart diseases, safety, mitral valve, therapeutics, mitral valve insufficiency | J Am Heart Assoc | 2026 | 0 |
| Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial. PMID 42558055 — stents, constriction, pathologic, cardiovascular surgical procedures, paclitaxel, pharmaceutical preparations, arteries, risk factors, therapeutics, catheters | Circ Cardiovasc Interv | 2026 | 2 |
| Incidence and Predictors of Complications After Transcatheter Aortic Valve Implantation According to VARC-3 Criteria: A Systematic Review and Meta-Analysis. PMID 42808440 — mortality, heart diseases, hemorrhage, stroke, incidence, kidney, drug-related side effects and adverse reactions, aortic valve, transcatheter aortic valve replacement, acute kidney injury | J Am Heart Assoc | 2026 | 1 |
Clinical Studies 49
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
19 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| ANDREAS Registry (Assessment of Novel Drug coated Balloon Revascularization Effectiveness Angiographic Outcomes and Safety) NCT07559903 — registries, safety, coronary artery disease, pharmaceutical preparations, percutaneous coronary intervention, arteries | N/A | Recruiting | 2026 |
| MITRAClip GENeration 5 Mitral Valve Transcatheter Edge to Edge Repair Registry NCT07543874 — registries, mitral valve, heart, mitral valve insufficiency | N/A | Not yet recruiting | 2026 |
| Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation NCT07321899 — heart valve diseases, pharmaceutical preparations, heart, tricuspid valve, drug delivery systems, tricuspid valve insufficiency, heart valves | N/A | Recruiting | 2026 |
| Early Feasibility Study (EFS) of Abbott s Balloon expandable (BE) TAVI System for the Treatment of Severe Symptomatic Aortic Stenosis NCT07116551 — constriction, pathologic, feasibility studies, aortic valve stenosis, cardiovascular diseases, aortic valve, transcatheter aortic valve replacement, therapeutics | N/A | Active not recruiting | 2025 |
| AMEND TS Early Feasibility Study NCT06951672 — comorbidity, feasibility studies, safety, mitral valve, heart, multiple chronic conditions, solutions, therapeutics, mitral valve insufficiency, heart valves | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map